BIONOMICS LIMITED - AMERICAN DEPOSITORY SHARES

Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement

08 نوفمبر 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at the 2024 CNS Summit

07 نوفمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program

04 نوفمبر 2024 16:15:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at the ThinkEquity Conference

23 أكتوبر 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC

14 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Issues Shareholder Letter Highlighting Recent Achievements and Strategic Vision

07 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Limited announces intention to re-domicile to the United States

01 أكتوبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

03 سبتمبر 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder

31 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024

29 يوليو 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder

18 يوليو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Bionomics Limited Announces Private Placement of up to $70.0 Million

31 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

20 مايو 2024 06:30:00 بحسب Nasdaq GlobeNewswire

Bionomics Reports Results of the Full Dataset Analysis from ATTUNE Phase 2b Trial of BNC210 in Patients with Post-Traumatic Stress Disorder

21 مارس 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at the 2024 BIO CEO & Investor Conference

22 فبراير 2024 16:30:00 بحسب Nasdaq GlobeNewswire

Bionomics Provides a Review of 2023 and of 2024 Plans

22 يناير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Bionomics to Present at Biotech Showcase™ 2024

05 يناير 2024 06:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Presents Detailed Data on the Validity and Reliability of the Subjective Units of Distress Scale at the 2023 American College of Neuropsychopharmacology Annual Meeting

06 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA and Solidifies Plans to Initiate the Registrational Program for BNC210 in Social Anxiety Disorder

16 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)

28 سبتمبر 2023 06:00:52 بحسب Nasdaq GlobeNewswire